Healthcare

Guided Biofilm Therapy, commonly abbreviated as GBT, is a standardized clinical protocol that combines biofilm detection, air polishing with low-abrasive powders, and selective ultrasonic debridement into a single, repeatable workflow for removing dental biofilm and calculus. Rather than defaulting to traditional hand-scaling as the first line of treatment, GBT reorders the sequence of care around

The global Actinium-225 radiopharmaceutical supply and targeted alpha therapy market is valued at USD 685 million in 2025 and is projected to reach USD 1,540 million by 2030, expanding at a compound annual growth rate of 17.6% across the forecast period.

Spatial mass spectrometry imaging has moved from a specialized academic technique to a core capability inside pharmaceutical discovery, translational research, and precision oncology programs. The technology fuses mass spectrometry's molecular specificity with pixel-by-pixel spatial mapping, letting scientists see where a drug, lipid, protein, or metabolite sits inside a tissue section rather

The North America Medicare Advantage platform market is moving through a rare convergence of pressures landing on health plans in the same budget cycle: enrollment growth, margin compression, and a wave of CMS-driven technology mandates. Valued at $3.05 billion in 2025, the market is projected to reach $4.78 billion by 2030, expanding at a 9.4% compound annual growth rate across the 2026–203

The global Guided Biofilm Therapy (GBT) market is valued at an estimated $1,050 million in 2025 and is projected to reach approximately $1,705 million by 2030, expanding at a CAGR of around 10.2% over the forecast period. Growth is being driven by the shift toward minimally invasive periodontal and peri-implant maintenance, the standardization of biofilm-management protocols across dental service

Structural heart programs worldwide are treating a growing volume of valvular stenosis cases with catheter-based tools rather than open surgery, and valvuloplasty balloon catheters sit at the center of that shift. The global valvuloplasty balloon catheters market is valued in the low single-digit billions in 2025 and is on a steady growth path through 2030, propelled by an aging population, expand

The clinical trial statistical programming services market covers the outsourced SDTM, ADaM and TFL programming, CDISC data conversion, submission package preparation, validation and real-world evidence programming that pharmaceutical, biotechnology and medical device sponsors buy to turn raw clinical trial data into regulatory-grade analysis and submission deliverables. Statistical programming s

The global AI-powered cardiac imaging and cardiovascular diagnostics market covers software and platforms that apply machine learning and deep learning to cardiac CT, MRI, echocardiography, and X-ray-derived images to automate measurement, detect disease, and support clinical decision-making across cardiovascular care.

The European digital pathology market is undergoing fundamental transformation. What began as imaging technology adoption is now evolving into a comprehensive workflow orchestration challenge—one that pathology organizations, hospital systems, and healthcare providers must resolve to remain competitive.

The global API CDMO market represents one of the most strategically important segments in pharmaceutical manufacturing today. Valued at $2.6 billion in 2026, the market is projected to expand to $3.2 billion by 2030, representing a compound annual growth rate of 5.2%.